RA CAPITAL MANAGEMENT, L.P.

Holdings History for Werewolf Therapeutics, Inc. - Common Stock (HOWL)

Symbol: HOWL on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 6,681,307 shares
Security Ownership %: 14%

Shares, Excluding Options vs Price

Value, Excluding Options

RA Capital Management, L.P. ownership in Werewolf Therapeutics, Inc. Common Stock (HOWL)

06 Nov 2025 - RA Capital Management, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,681,307 shares of Werewolf Therapeutics, Inc. Common Stock (HOWL). This represents 14% ownership of the company. In their previous filing dated 14 May 2025, RA CAPITAL MANAGEMENT, L.P. had reported owning 6,746,807 shares, indicating a decrease of +0.97%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
RA Capital Management, L.P.	14%	-8%	$13,162,175	6,681,307	-65,500	-0.97%	$1.97	13D/A	04 Nov 2025	06 Nov 2025, 16:29
RA Capital Management, L.P.	15%		$6,072,126	6,746,807			$0.90	13D/A	12 May 2025	14 May 2025, 18:09

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.04%	0%	$4,232,608	6,681,307	0		$0.63	Q4 2025
30 Sep 2025	0.16%	0%	$13,162,175	6,681,307	0		$1.97	Q3 2025
30 Jun 2025	0.12%	+0.01%	$7,282,625	6,681,307	+536,426	+8.7%	$1.09	Q2 2025
31 Mar 2025	0.1%	0%	$5,974,053	6,144,881	0		$0.97	Q1 2025
31 Dec 2024	0.12%	0%	$9,094,424	6,144,881	0		$1.48	Q4 2024
30 Sep 2024	0.15%	0%	$13,027,148	6,144,881	0		$2.12	Q3 2024
30 Jun 2024	0.2%	0%	$14,993,510	6,144,881	0		$2.44	Q2 2024
31 Mar 2024	0.51%	0%	$39,818,829	6,144,881	0		$6.48	Q1 2024
31 Dec 2023	0.37%	0%	$23,719,241	6,144,881	0		$3.86	Q4 2023
30 Sep 2023	0.26%	0%	$13,150,045	6,144,881	0		$2.14	Q3 2023
30 Jun 2023	0.35%	0%	$18,741,887	6,144,881	0		$3.05	Q2 2023
31 Mar 2023	0.36%	+0.11%	$15,976,691	6,144,881	+1,853,000	+43%	$2.60	Q1 2023
31 Dec 2022	0.18%	0%	$8,798,356	4,291,881	0		$2.05	Q4 2022
30 Sep 2022	0.41%	0%	$19,356,000	4,291,881	0		$4.51	Q3 2022
30 Jun 2022	0.47%	0%	$17,554,000	4,291,881	0		$4.09	Q2 2022
31 Mar 2022	0.41%	0%	$18,884,000	4,291,881	0		$4.40	Q1 2022
31 Dec 2021	0.9%	0%	$51,116,000	4,291,881	0		$11.91	Q4 2021
30 Sep 2021	1%	0%	$73,649,000	4,291,881	0		$17.16	Q3 2021
30 Jun 2021	1.2%	+1.2%	$74,850,000	4,291,881	+4,291,881	NEW	$17.44	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.